Michiels, S., Mauguen, A., Fisher, D., Burdett, S., Paulus, R., Mandrekar, S. J., … Pignon, J. (2011). Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer. Journal of Clinical Oncology, 29(15_suppl), 7004–7004. https://doi.org/10.1200/jco.2011.29.15_suppl.7004

Michiels, S., A. Mauguen, D. Fisher, S. Burdett, R. Paulus, S. J. Mandrekar, C. P. Belani, et al. “Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer.” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 7004–7004. https://doi.org/10.1200/jco.2011.29.15_suppl.7004.

Michiels S, Mauguen A, Fisher D, Burdett S, Paulus R, Mandrekar SJ, et al. Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer. Journal of Clinical Oncology. 2011 May 20;29(15_suppl):7004–7004.

Michiels, S., et al. “Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2011, pp. 7004–7004. Crossref, doi:10.1200/jco.2011.29.15_suppl.7004.

Michiels S, Mauguen A, Fisher D, Burdett S, Paulus R, Mandrekar SJ, Belani CP, Shepherd FA, Eisen T, Pang H, Collette L, Le Pechoux C, Pignon J. Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011 May 20;29(15_suppl):7004–7004.